World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
46444
World Ranking
9505
National Ranking
373

Overview

Mario Talajic is affiliated with the Montreal Heart Institute in Canada. The primary field of study is Medicine, with a focus on cardiology and cardiovascular medicine. Their research also spans molecular biology, genetics, emergency medicine, and surgery.

The main topics covered in Mario Talajic's work include:

  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Effects of Exercise
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrest and Resuscitation

Mario Talajic has published extensively, with notable papers including:

  • The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation, 2020, Canadian Journal of Cardiology
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect, 2021, Nature Genetics
  • A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy, 2022, European Heart Journal
  • Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy, 2020, Circulation Arrhythmia and Electrophysiology

Frequent co-authors of Mario Talajic include:

  • Rafik Tadros
  • Julia Cadrin-Tourigny
  • Andrew D. Krahn
  • Zachary Laksman
  • Jeff S. Healey

Regular publication venues for Mario Talajic's work are:

  • Canadian Journal of Cardiology
  • Heart Rhythm
  • CJC Open
  • JACC. Clinical electrophysiology
  • Circulation Genomic and Precision Medicine

Best Publications

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • Depression Following Myocardial Infarction: Impact on 6-Month Survival

    Nancy Frasure-Smith;François Lespérance;Mario Talajic

  • Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

    Anthony S. L. Tang;George A. Wells;Mario Talajic;Malcolm O. Arnold

  • Rhythm control versus rate control for atrial fibrillation and heart failure

    Denis Roy;Mario Talajic;Stanley Nattel;D. George Wyse

  • Amiodarone to Prevent Recurrence of Atrial Fibrillation

    Denis Roy;Mario Talajic;Paul Dorian;Stuart Connolly

  • Prognostic importance of defibrillator shocks in patients with heart failure.

    Jeanne E. Poole;George W. Johnson;Anne S. Hellkamp;Jill Anderson

  • Five-Year Risk of Cardiac Mortality in Relation to Initial Severity and One-Year Changes in Depression Symptoms After Myocardial Infarction

    François Lespérance;Nancy Frasure-Smith;Mario Talajic;Martial G. Bourassa

  • Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes

    Stuart J. Connolly;Charles R. Kerr;Michael Gent;Robin S. Roberts

  • Social support, depression, and mortality during the first year after myocardial infarction.

    Nancy Frasure-Smith;François Lespérance;Ginette Gravel;Aline Masson

  • Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators: The OPTIC Study: A Randomized Trial

    Stuart J. Connolly;Paul Dorian;Robin S. Roberts;Michael Gent

  • Gender, depression, and one-year prognosis after myocardial infarction.

    Nancy Frasure-Smith;François Lespérance;Martin Juneau;Mario Talajic

  • Major depression before and after myocardial infarction: its nature and consequences.

    Francois Lesperance;Nancy Frasure-Smith;Mario Talajic

  • The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?

    Nancy Frasure-Smith;François Lespérance;Mario Talajic

  • Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death

    A E Buxton;K L Lee;L DiCarlo;M R Gold

  • Functional Mechanisms Underlying Tachycardia-Induced Sustained Atrial Fibrillation in a Chronic Dog Model

    Rania Gaspo;Ralph F. Bosch;Mario Talajic;Stanley Nattel

  • Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

    Charles R. Kerr;Karin H. Humphries;Mario Talajic;George J. Klein

  • Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

    Riccardo Cappato;Michael D. Ezekowitz;Allan L. Klein;A. John Camm

  • New-Onset Atrial Fibrillation : Sex Differences in Presentation, Treatment, and Outcome

    Karin H. Humphries;Charles R. Kerr;Stuart J. Connolly;George Klein

  • Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies

    Jason G. Andrade;Paul Khairy;Peter G. Guerra;Marc W. Deyell

  • Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

    John A. Cairns;Stuart Connolly;Sean McMurtry;Michael Stephenson

Frequent Co-Authors

Paul Khairy
Paul Khairy Montreal Heart Institute
Stanley Nattel
Stanley Nattel Montreal Heart Institute
Stuart J. Connolly
Stuart J. Connolly McMaster University
Jean-Claude Tardif
Jean-Claude Tardif Montreal Heart Institute
Paul Dorian
Paul Dorian University of Toronto
Jeff S. Healey
Jeff S. Healey Population Health Research Institute
Andrew D. Krahn
Andrew D. Krahn University of British Columbia
George Klein
George Klein Karolinska Institute
George J. Klein
George J. Klein University of Western Ontario
Raymond Yee
Raymond Yee University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse and flexible education options, especially for students balancing work and study. Many nursing professionals are turning to online rn to bsn programs no clinicals, which allow registered nurses to earn their BSN without the traditional in-person requirements, making career advancement more accessible.

For those aiming to reach the highest level in nursing, shortest dnp programs online provide a streamlined route to a doctorate. These accelerated pathways can help professionals achieve advanced roles more quickly, without compromising on quality. If you are seeking flexibility, the easiest dnp program online options prioritize user-friendly curriculums, designed to support working nurses in completing their studies efficiently.

Starting your nursing journey is also faster than ever. With an lpn accelerated program, you can quickly begin a practical nursing career and build a strong foundation in the healthcare sector. These online education pathways make it easier to adapt your studies to your lifestyle while pursuing a rewarding medical career in the US.

Best Scientists Citing Mario Talajic

Trending Scientists